Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

The mechanisms and physiological relevance of glycocalyx degradation in hepatic ischemia/reperfusion injury.

van Golen RF, Reiniers MJ, Vrisekoop N, Zuurbier CJ, Olthof PB, van Rheenen J, van Gulik TM, Parsons BJ, Heger M.

Antioxid Redox Signal. 2014 Sep 1;21(7):1098-118. doi: 10.1089/ars.2013.5751. Epub 2014 Feb 19. Review.

2.

Mechanistic overview of reactive species-induced degradation of the endothelial glycocalyx during hepatic ischemia/reperfusion injury.

van Golen RF, van Gulik TM, Heger M.

Free Radic Biol Med. 2012 Apr 15;52(8):1382-402. doi: 10.1016/j.freeradbiomed.2012.01.013. Epub 2012 Jan 31. Review.

PMID:
22326617
3.

Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury.

Rubio-Gayosso I, Platts SH, Duling BR.

Am J Physiol Heart Circ Physiol. 2006 Jun;290(6):H2247-56. Epub 2006 Jan 6.

4.

Notch signal protects non-parenchymal cells from ischemia/reperfusion injury in vitro by repressing ROS.

Yu HC, Bai L, Yue SQ, Wang DS, Wang L, Han H, Dou KF.

Ann Hepatol. 2013 Sep-Oct;12(5):815-21.

5.

Sterile inflammation in hepatic ischemia/reperfusion injury: present concepts and potential therapeutics.

van Golen RF, Reiniers MJ, Olthof PB, van Gulik TM, Heger M.

J Gastroenterol Hepatol. 2013 Mar;28(3):394-400. doi: 10.1111/jgh.12072. Review.

PMID:
23216461
6.

Reactive oxygen species mediate human hepatocyte injury during hypoxia/reoxygenation.

Bhogal RH, Curbishley SM, Weston CJ, Adams DH, Afford SC.

Liver Transpl. 2010 Nov;16(11):1303-13. doi: 10.1002/lt.22157.

7.

Reactive oxygen species mediate liver injury through parenchymal nuclear factor-kappaB inactivation in prolonged ischemia/reperfusion.

Llacuna L, Marí M, Lluis JM, García-Ruiz C, Fernández-Checa JC, Morales A.

Am J Pathol. 2009 May;174(5):1776-85. doi: 10.2353/ajpath.2009.080857. Epub 2009 Apr 6.

8.

Reactive oxygen and nitrogen species in steatotic hepatocytes: a molecular perspective on the pathophysiology of ischemia-reperfusion injury in the fatty liver.

Reiniers MJ, van Golen RF, van Gulik TM, Heger M.

Antioxid Redox Signal. 2014 Sep 1;21(7):1119-42. doi: 10.1089/ars.2013.5486. Epub 2014 Feb 19. Review.

9.

Propofol attenuates the decrease of dynamic compliance and water content in the lung by decreasing oxidative radicals released from the reperfused liver.

Chan KC, Lin CJ, Lee PH, Chen CF, Lai YL, Sun WZ, Cheng YJ.

Anesth Analg. 2008 Oct;107(4):1284-9. doi: 10.1213/ane.0b013e318181f4e6.

PMID:
18806041
10.

Hydroxysafflor yellow A attenuates ischemia/reperfusion-induced liver injury by suppressing macrophage activation.

Jiang S, Shi Z, Li C, Ma C, Bai X, Wang C.

Int J Clin Exp Pathol. 2014 Apr 15;7(5):2595-608. eCollection 2014.

11.

NO donor KMUP-1 improves hepatic ischemia-reperfusion and hypoxic cell injury by inhibiting oxidative stress and pro-inflammatory signaling.

Kuo KK, Wu BN, Chiu EY, Tseng CJ, Yeh JL, Liu CP, Chai CY, Chen IJ.

Int J Immunopathol Pharmacol. 2013 Jan-Mar;26(1):93-106.

PMID:
23527712
12.

Xanthohumol suppresses inflammatory response to warm ischemia-reperfusion induced liver injury.

Dorn C, Massinger S, Wuzik A, Heilmann J, Hellerbrand C.

Exp Mol Pathol. 2013 Feb;94(1):10-6. doi: 10.1016/j.yexmp.2012.05.003. Epub 2012 May 23.

PMID:
22634733
13.

Prevention of hepatic ischemia-reperfusion injury by pre-administration of catalase-expressing adenovirus vectors.

Ushitora M, Sakurai F, Yamaguchi T, Nakamura S, Kondoh M, Yagi K, Kawabata K, Mizuguchi H.

J Control Release. 2010 Mar 19;142(3):431-7. doi: 10.1016/j.jconrel.2009.11.024. Epub 2009 Nov 29.

PMID:
19951728
14.

Therapeutic potential of pegylated hemin for reactive oxygen species-related diseases via induction of heme oxygenase-1: results from a rat hepatic ischemia/reperfusion injury model.

Fang J, Qin H, Seki T, Nakamura H, Tsukigawa K, Shin T, Maeda H.

J Pharmacol Exp Ther. 2011 Dec;339(3):779-89. doi: 10.1124/jpet.111.185348. Epub 2011 Sep 2.

15.

Liver ischemia/reperfusion injury: processes in inflammatory networks--a review.

Abu-Amara M, Yang SY, Tapuria N, Fuller B, Davidson B, Seifalian A.

Liver Transpl. 2010 Sep;16(9):1016-32. doi: 10.1002/lt.22117. Review.

16.

Dihydrolipoyl histidinate zinc complex, a new antioxidant, attenuates hepatic ischemia-reperfusion injury in rats.

Masuda T, Iwashita Y, Hagiwara S, Ohta M, Inomata M, Noguchi T, Kitano S.

J Gastroenterol Hepatol. 2011 Nov;26(11):1652-8. doi: 10.1111/j.1440-1746.2011.06773.x.

PMID:
22011298
17.

Multiphoton microscopy can visualize zonal damage and decreased cellular metabolic activity in hepatic ischemia-reperfusion injury in rats.

Thorling CA, Liu X, Burczynski FJ, Fletcher LM, Gobe GC, Roberts MS.

J Biomed Opt. 2011 Nov;16(11):116011. doi: 10.1117/1.3647597.

PMID:
22112116
18.

Reactive oxygen species modulate the barrier function of the human glomerular endothelial glycocalyx.

Singh A, Ramnath RD, Foster RR, Wylie EC, Fridén V, Dasgupta I, Haraldsson B, Welsh GI, Mathieson PW, Satchell SC.

PLoS One. 2013;8(2):e55852. doi: 10.1371/journal.pone.0055852. Epub 2013 Feb 14.

19.

Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice.

Teoh NC, Ito Y, Field J, Bethea NW, Amr D, McCuskey MK, McCuskey RS, Farrell GC, Allison AC.

Gastroenterology. 2007 Aug;133(2):632-46. Epub 2007 May 21.

PMID:
17681182
20.

Cooperation of liver cells in health and disease.

Kmieć Z.

Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. Review.

PMID:
11729749
Items per page

Supplemental Content

Write to the Help Desk